{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:06:10Z","timestamp":1768532770284,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/07\/X\/NZ4\/00338"],"award-info":[{"award-number":["2023\/07\/X\/NZ4\/00338"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      is a major cause of hospital-acquired pneumonia, with methicillin-resistant strains contributing significantly to prolonged illness and mortality. Methicillin-resistant strains can be responsible for up to 75% of infections in certain countries. Therefore, the problem is described as severe, and the search for alternative methods of treatment of such infections is currently one of the priorities in healthcare. Bacteriophages, although historically underutilized, are re-gaining interest for their potential in treating bacterial infections. However, they do have their limitations such as specific ranges of activity and resistance development. Combining phages with antimicrobial agents such as lactoferrin\u2014a natural protein with antimicrobial and anti-biofilm properties\u2014may improve treatment outcomes. In this study, we evaluated the efficacy of three Kayviruses paired with lactoferrin against MRSA in infected pulmonary epithelial cell cultures. The combination significantly reduced bacterial viability, protected human cells from cytotoxic effects of bacterial infection, and decreased inflammasome activation. These findings suggest that phage-lactoferrin combinations may offer a promising, safer alternative for managing MRSA-related pneumonia and reducing dependence on traditional antibiotics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key points<\/jats:title>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>Phage lactoferrin mixture had no influence on A549 cells<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>Lactoferrin increased phage efficacy and reduced influence of bacteria on cells<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>Phage\u2009+\u2009Lf mixture limited inflammatory response similarly to phages and Lf alone<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00253-025-13695-9","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:03:43Z","timestamp":1768068223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells"],"prefix":"10.1007","volume":"110","author":[{"given":"Katarzyna","family":"Kosznik-Kwa\u015bnicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Stasi\u0142oj\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Grzenkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Stasi\u0142oj\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Necel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Piechowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"13695_CR1","doi-asserted-by":"publisher","unstructured":"Alwakeel M, Obeidat M, Nanah A, Abdeljaleel F, Wang X, Fadell F (2025) Evaluating the diagnostic performance of nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction in hospital-acquired pneumonia within the intensive care unit. A retrospective study. J Intensive Care Med 40:54\u201359. https:\/\/doi.org\/10.1177\/08850666241264774","DOI":"10.1177\/08850666241264774"},{"key":"13695_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102287","volume":"24","author":"MC Bichet","year":"2021","unstructured":"Bichet MC, Chin WH, Richards W, Lin Y-W, Avellaneda-Franco L, Hernandez CA, Oddo A, Chernyavskiy O, Hilsenstein V, Neild A et al (2021) Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy. iScience 24:102287. https:\/\/doi.org\/10.1016\/j.isci.2021.102287","journal-title":"iScience"},{"key":"13695_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chom.2019.01.020","volume":"25","author":"PL Bollyky","year":"2019","unstructured":"Bollyky PL, Secor PR (2019) The innate sense of bacteriophages. Cell Host Microbe 25:177\u2013179. https:\/\/doi.org\/10.1016\/j.chom.2019.01.020","journal-title":"Cell Host Microbe"},{"key":"13695_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/infdis\/jiy210","volume":"218","author":"TR Borgogna","year":"2018","unstructured":"Borgogna TR, Hisey B, Heitmann E, Obar JJ, Meissner N, Voyich JM (2018) Secondary bacterial pneumonia by Staphylococcus aureus following influenza A infection is SaeR\/S dependent. J Infect Dis 218:809\u2013813. https:\/\/doi.org\/10.1093\/infdis\/jiy210","journal-title":"J Infect Dis"},{"key":"13695_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung GYC, Bae JS, Otto M (2021) Pathogenicity and virulence of Staphylococcus aureus. Virulence 12:547\u2013569. https:\/\/doi.org\/10.1080\/21505594.2021.1878688","journal-title":"Virulence"},{"key":"13695_CR6","unstructured":"Clark SB, Hicks MA (2024) Staphylococcal pneumonia. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"13695_CR7","doi-asserted-by":"publisher","first-page":"389S","DOI":"10.1080\/07315724.2001.10719173","volume":"20","author":"OM Conneely","year":"2001","unstructured":"Conneely OM (2001) Antiinflammatory activities of lactoferrin. J Am Coll Nutr 20:389S-395S. https:\/\/doi.org\/10.1080\/07315724.2001.10719173","journal-title":"J Am Coll Nutr"},{"key":"13695_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00012-19","volume":"83","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K, Abedon ST (2019) Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies. Microbiol Mol Biol Rev 83:10.1128\/mmbr.00012-19. https:\/\/doi.org\/10.1128\/mmbr.00012-19","journal-title":"Microbiol Mol Biol Rev"},{"key":"13695_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-9-13","volume":"9","author":"K D\u0105browska","year":"2009","unstructured":"D\u0105browska K, Skaradzi\u0144ski G, Jo\u0144czyk P, Kurz\u0119pa A, Wietrzyk J, Owczarek B, \u017baczek M, \u015awita\u0142a-Jele\u0144 K, Boraty\u0144ski J, Po\u017aniak G et al (2009) The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration. BMC Microbiol 9:13. https:\/\/doi.org\/10.1186\/1471-2180-9-13","journal-title":"BMC Microbiol"},{"key":"13695_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10096-015-2566-8","volume":"35","author":"C De la Calle","year":"2016","unstructured":"De la Calle C, Morata L, Cobos-Trigueros N, Martinez JA, Cardozo C, Mensa J, Soriano A (2016) Staphylococcus aureus bacteremic pneumonia. Eur J Clin Microbiol Infect Dis 35:497\u2013502. https:\/\/doi.org\/10.1007\/s10096-015-2566-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13695_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-6-2","volume":"6","author":"J Delaney","year":"2008","unstructured":"Delaney J, Schneider-Lindner V, Brassard P, Suissa S (2008) Mortality after infection with methicillin-resistant Staphylococcus aureus(MRSA) diagnosed in the community. BMC Med 6:2. https:\/\/doi.org\/10.1186\/1741-7015-6-2","journal-title":"BMC Med"},{"key":"13695_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030501","volume":"18","author":"ME Drago-Serrano","year":"2017","unstructured":"Drago-Serrano ME, Campos-Rodr\u00edguez R, Carrero JC, la De Garza M (2017) Lactoferrin: balancing ups and downs of inflammation due to microbial infections. Int J Mol Sci 18:501. https:\/\/doi.org\/10.3390\/ijms18030501","journal-title":"Int J Mol Sci"},{"key":"13695_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0161-5890(03)00152-4","volume":"40","author":"S Farnaud","year":"2003","unstructured":"Farnaud S, Evans RW (2003) Lactoferrin\u2014a multifunctional protein with antimicrobial properties. Mol Immunol 40:395\u2013405. https:\/\/doi.org\/10.1016\/S0161-5890(03)00152-4","journal-title":"Mol Immunol"},{"key":"13695_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00284-015-0968-6","volume":"72","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Ricke SC, Almeida G, Gibson KE (2016) Combined application of essential oil compounds and bacteriophage to inhibit growth of Staphylococcus aureus in vitro. Curr Microbiol 72:426\u2013435. https:\/\/doi.org\/10.1007\/s00284-015-0968-6","journal-title":"Curr Microbiol"},{"key":"13695_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/med.21593","volume":"40","author":"A G\u00f3rski","year":"2020","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, W\u0119grzyn G, Jo\u0144czyk-Matysiak E, Borysowski J, Weber-D\u0105browska B (2020) Phage therapy: current status and perspectives. Med Res Rev 40:459\u2013463. https:\/\/doi.org\/10.1002\/med.21593","journal-title":"Med Res Rev"},{"key":"13695_CR16","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1093\/cid\/ciad483","volume":"77","author":"A G\u00f3rski","year":"2023","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, Jo\u0144czyk-Matysiak E, Kniotek M, Letkiewicz S (2023) Therapeutic phages as modulators of the immune response: practical implications. Clin Infect Dis 77:S433\u2013S439. https:\/\/doi.org\/10.1093\/cid\/ciad483","journal-title":"Clin Infect Dis"},{"key":"13695_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107872","author":"M Grzenkowicz","year":"2025","unstructured":"Grzenkowicz M, Ka\u017amierczak N, Piechowicz L, Kosznik-Kwa\u015bnicka K (2025) Stimulating effect of lactoferrin on antibacterial efficacy of VB_SauM-A phage against multi-drug resistant strains of Staphylococcus aureus. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2025.107872","journal-title":"Microb Pathog"},{"key":"13695_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107872","volume":"207","author":"M Grzenkowicz","year":"2025","unstructured":"Grzenkowicz M, Ka\u017amierczak N, Piechowicz L, Kosznik-Kwa\u015bnicka K (2025) Stimulating effect of lactoferrin on antibacterial efficacy of vB_SauM-A phage against multi-drug resistant strains of Staphylococcus aureus. Microb Pathog 207:107872. https:\/\/doi.org\/10.1016\/j.micpath.2025.107872","journal-title":"Microb Pathog"},{"key":"13695_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13756-023-01210-6","volume":"12","author":"AH Hasanpour","year":"2023","unstructured":"Hasanpour AH, Sepidarkish M, Mollalo A, Ardekani A, Almukhtar M, Mechaal A, Hosseini SR, Bayani M, Javanian M, Rostami A (2023) The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis. Antimicrob Resist Infect Control 12:4. https:\/\/doi.org\/10.1186\/s13756-023-01210-6","journal-title":"Antimicrob Resist Infect Control"},{"key":"13695_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2174\/1389200216666151001121004","volume":"16","author":"K Kishor","year":"2015","unstructured":"Kishor K, Dhasmana N, Kamble SS, Sahu RK (2015) Linezolid induced adverse drug reactions - an update. Curr Drug Metab 16:553\u2013559. https:\/\/doi.org\/10.2174\/1389200216666151001121004","journal-title":"Curr Drug Metab"},{"key":"13695_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091256","volume":"11","author":"K Kosznik-Kwa\u015bnicka","year":"2022","unstructured":"Kosznik-Kwa\u015bnicka K, Ka\u017amierczak N, Piechowicz L (2022) Activity of phage-lactoferrin mixture against multi drug resistant Staphylococcus aureus biofilms. Antibiotics 11:1256. https:\/\/doi.org\/10.3390\/antibiotics11091256","journal-title":"Antibiotics"},{"key":"13695_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.609459","author":"M Kumar","year":"2021","unstructured":"Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Nina PB, Jp D, Kumar S, Singh B, Tiwari RR (2021) Futuristic non-antibiotic therapies to combat antibiotic resistance: a review. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.609459","journal-title":"Front Microbiol"},{"key":"13695_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9090547","volume":"9","author":"F Lamret","year":"2020","unstructured":"Lamret F, Colin M, Mongaret C, Gangloff SC, Reffuveille F (2020) Antibiotic tolerance of Staphylococcus aureus biofilm in periprosthetic joint infections and antibiofilm strategies. Antibiotics 9:547. https:\/\/doi.org\/10.3390\/antibiotics9090547","journal-title":"Antibiotics"},{"key":"13695_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/v13010060","volume":"13","author":"D Lebeaux","year":"2021","unstructured":"Lebeaux D, Merabishvili M, Caudron E, Lannoy D, Van Simaey L, Duyvejonck H, Guillemain R, Thumerelle C, Podglajen I, Compain F et al (2021) A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient. Viruses 13:60. https:\/\/doi.org\/10.3390\/v13010060","journal-title":"Viruses"},{"key":"13695_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/molecules27061857","volume":"27","author":"J Lin","year":"2022","unstructured":"Lin J, Du F, Long M, Li P (2022) Limitations of phage therapy and corresponding optimization strategies: a review. Molecules 27:1857. https:\/\/doi.org\/10.3390\/molecules27061857","journal-title":"Molecules"},{"key":"13695_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1:111\u2013114. https:\/\/doi.org\/10.4161\/bact.1.2.14590","journal-title":"Bacteriophage"},{"key":"13695_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1356179","author":"A Loganathan","year":"2024","unstructured":"Loganathan A, Bozdogan B, Manohar P, Nachimuthu R (2024) Phage-antibiotic combinations in various treatment modalities to manage MRSA infections. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1356179","journal-title":"Front Pharmacol"},{"key":"13695_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7100471","volume":"7","author":"N \u0141ubowska","year":"2019","unstructured":"\u0141ubowska N, Grygorcewicz B, Kosznik-Kwa\u015bnicka K, Zauszkiewicz-Pawlak A, W\u0119grzyn A, Do\u0142\u0119gowska B, Piechowicz L (2019) Characterization of the three new kayviruses and their lytic activity against multidrug-resistant Staphylococcus aureus. Microorganisms 7:471. https:\/\/doi.org\/10.3390\/microorganisms7100471","journal-title":"Microorganisms"},{"key":"13695_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13049-019-0596-4","volume":"27","author":"H Minasyan","year":"2019","unstructured":"Minasyan H (2019) Sepsis: mechanisms of bacterial injury to the patient. Scand J Trauma Resusc Emerg Med 27:19. https:\/\/doi.org\/10.1186\/s13049-019-0596-4","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"13695_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1128\/iai.70.2.620-630.2002","volume":"70","author":"E Mongodin","year":"2002","unstructured":"Mongodin E, Bajolet O, Cutrona J, Bonnet N, Dupuit F, Puchelle E, de Bentzmann S (2002) Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium. Infect Immun 70:620\u2013630. https:\/\/doi.org\/10.1128\/iai.70.2.620-630.2002","journal-title":"Infect Immun"},{"key":"13695_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02068-16","volume":"7","author":"ME Mulcahy","year":"2016","unstructured":"Mulcahy ME, McLoughlin RM (2016) Staphylococcus aureus and influenza A virus: partners in coinfection. mBio 7:10.1128\/mbio.02068-16. https:\/\/doi.org\/10.1128\/mbio.02068-16","journal-title":"mBio"},{"key":"13695_CR32","doi-asserted-by":"publisher","unstructured":"Nguyen S, Baker K, Padman BS, Patwa R, Dunstan RA, Weston TA, Schlosser K, Bailey B, Lithgow T, Lazarou M et al (2017) Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 8. https:\/\/doi.org\/10.1128\/mbio.01874-17","DOI":"10.1128\/mbio.01874-17"},{"key":"13695_CR33","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/S0140-6736(05)66759-1","volume":"365","author":"T Parfitt","year":"2005","unstructured":"Parfitt T (2005) Georgia: an unlikely stronghold for bacteriophage therapy. Lancet 365:2166\u20132167. https:\/\/doi.org\/10.1016\/S0140-6736(05)66759-1","journal-title":"Lancet"},{"key":"13695_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.668900","author":"A Petersen","year":"2021","unstructured":"Petersen A, Larssen KW, Gran FW, Enger H, H\u00e6ggman S, M\u00e4kitalo B, Haraldsson G, Lindholm L, Vuopio J, Henius AE et al (2021) Increasing incidences and clonal diversity of methicillin-resistant Staphylococcus aureus in the Nordic countries - results from the Nordic MRSA surveillance. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.668900","journal-title":"Front Microbiol"},{"key":"13695_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810050","volume":"25","author":"L Piechowicz","year":"2024","unstructured":"Piechowicz L, Kosznik-Kwa\u015bnicka K, Jarzembowski T, Daca A, Necel A, Bonawenturczak A, Werbowy O, Stasi\u0142oj\u0107 M, Pa\u0142ubicka A (2024) Staphylococcus aureus co-infection in COVID-19 patients: virulence genes and their influence on respiratory epithelial cells in light of risk of severe secondary infection. Int J Mol Sci 25:10050. https:\/\/doi.org\/10.3390\/ijms251810050","journal-title":"Int J Mol Sci"},{"key":"13695_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030257","volume":"14","author":"L Piechowicz","year":"2025","unstructured":"Piechowicz L, Kosznik-Kwa\u015bnicka K, Ka\u017amierczak N, Grzenkowicz M, Stasi\u0142oj\u0107 M, Necel A, Werbowy O, Pa\u0142ubicka A (2025) Efficacy of three kayviruses against Staphylococcus aureus strains isolated from COVID-19 patients. Antibiotics 14:257. https:\/\/doi.org\/10.3390\/antibiotics14030257","journal-title":"Antibiotics"},{"key":"13695_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/DHPS.S458284","volume":"16","author":"ZA Qamariat","year":"2024","unstructured":"Qamariat ZA, Aljaffar AA, Alabdulaal ZS, Alnezir F, Al-Zawad WM, Alqattan M, Almahdi A (2024) Rapid onset and recovery linezolid-induced thrombocytopenia: a large-sample, single-center retrospective cohort study. Drug Healthc Patient Saf 16:43\u201349. https:\/\/doi.org\/10.2147\/DHPS.S458284","journal-title":"Drug Healthc Patient Saf"},{"key":"13695_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/1348-0421.12738","volume":"63","author":"G Rasmussen","year":"2019","unstructured":"Rasmussen G, Idosa BA, B\u00e4ckman A, Monecke S, Str\u00e5lin K, S\u00e4rndahl E, S\u00f6derquist B (2019) Caspase\u20101 inflammasome activity in patients with Staphylococcus aureus bacteremia. Microbiol Immunol 63:487\u2013499. https:\/\/doi.org\/10.1111\/1348-0421.12738","journal-title":"Microbiol Immunol"},{"key":"13695_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc 3:1125\u20131131. https:\/\/doi.org\/10.1038\/nprot.2008.75","journal-title":"Nat Protoc"},{"key":"13695_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1564943","author":"TG R\u00f8nning","year":"2025","unstructured":"R\u00f8nning TG, Enger H, Afset JE, \u00c5s CG (2025) Trends and characteristics of multidrug-resistant MRSA in Norway 2008-2020. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2025.1564943","journal-title":"Front Microbiol"},{"key":"13695_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclepro.2024.143895","volume":"478","author":"R Ruiz-P\u00e9rez","year":"2024","unstructured":"Ruiz-P\u00e9rez R, Newman-Portela AM, Ruiz-Fresneda MA (2024) Emerging global trends in next-generation alternatives to classic antibiotics for combatting multidrug-resistant bacteria. J Clean Prod 478:143895. https:\/\/doi.org\/10.1016\/j.jclepro.2024.143895","journal-title":"J Clean Prod"},{"key":"13695_CR42","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1091\/mbc.e06-05-0463","volume":"17","author":"A Schr\u00f6der","year":"2006","unstructured":"Schr\u00f6der A, Schr\u00f6der B, Roppenser B, Linder S, Sinha B, F\u00e4ssler R, Aepfelbacher M (2006) Staphylococcus aureus fibronectin binding protein-A induces motile attachment sites and complex actin remodeling in living endothelial cells. Mol Biol Cell 17:5198\u20135210. https:\/\/doi.org\/10.1091\/mbc.e06-05-0463","journal-title":"Mol Biol Cell"},{"key":"13695_CR43","doi-asserted-by":"publisher","unstructured":"Shahbazi F (2025) Linezolid related adverse effects in different populations: a practical review. Curr Drug Saf. https:\/\/doi.org\/10.2174\/0115748863352325250311080624","DOI":"10.2174\/0115748863352325250311080624"},{"key":"13695_CR44","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41598-018-23418-y","volume":"8","author":"J Shan","year":"2018","unstructured":"Shan J, Ramachandran A, Thanki AM, Vukusic FBI, Barylski J, Clokie MRJ (2018) Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells. Sci Rep 8:5091. https:\/\/doi.org\/10.1038\/s41598-018-23418-y","journal-title":"Sci Rep"},{"key":"13695_CR45","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1128\/iai.69.5.3120-3127.2001","volume":"69","author":"IR Siboo","year":"2001","unstructured":"Siboo IR, Cheung AL, Bayer AS, Sullam PM (2001) Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 69:3120\u20133127. https:\/\/doi.org\/10.1128\/iai.69.5.3120-3127.2001","journal-title":"Infect Immun"},{"key":"13695_CR46","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/infdis\/jis244","volume":"205","author":"G Soong","year":"2012","unstructured":"Soong G, Chun J, Parker D, Prince A (2012) Staphylococcus aureus activation of caspase 1\/calpain signaling mediates invasion through human keratinocytes. J Infect Dis 205:1571\u20131579. https:\/\/doi.org\/10.1093\/infdis\/jis244","journal-title":"J Infect Dis"},{"key":"13695_CR47","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1038\/s41598-022-19922-x","volume":"12","author":"T Suda","year":"2022","unstructured":"Suda T, Hanawa T, Tanaka M, Tanji Y, Miyanaga K, Hasegawa-Ishii S, Shirato K, Kizaki T, Matsuda T (2022) Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection. Sci Rep 12:15656. https:\/\/doi.org\/10.1038\/s41598-022-19922-x","journal-title":"Sci Rep"},{"key":"13695_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4161\/bact.20757","volume":"2","author":"WC Summers","year":"2012","unstructured":"Summers WC (2012) The strange history of phage therapy. Bacteriophage 2:130\u2013133. https:\/\/doi.org\/10.4161\/bact.20757","journal-title":"Bacteriophage"},{"key":"13695_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082380","volume":"13","author":"AK Thabit","year":"2024","unstructured":"Thabit AK, Alghamdi AA, Alsaeed AK, Magbool NM, Alsowaida YS, Mahrous AJ, Alruwaili A, Albakistani ZK, Albangali BO, Alghumuy AM et al (2024) Linezolid-associated thrombocytopenia: assessment of risk factors in patients without hemato-oncologic diseases. J Clin Med 13:2380. https:\/\/doi.org\/10.3390\/jcm13082380","journal-title":"J Clin Med"},{"key":"13695_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1178526","author":"TJ Theis","year":"2023","unstructured":"Theis TJ, Daubert TA, Kluthe KE, Brodd KL, Nuxoll AS (2023) Staphylococcus aureus persisters are associated with reduced clearance in a catheter-associated biofilm infection. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2023.1178526","journal-title":"Front Cell Infect Microbiol"},{"key":"13695_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/0003-4819-97-3-309","volume":"97","author":"RL Thompson","year":"1982","unstructured":"Thompson RL, Cabezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97:309\u2013317. https:\/\/doi.org\/10.7326\/0003-4819-97-3-309","journal-title":"Ann Intern Med"},{"key":"13695_CR52","doi-asserted-by":"publisher","unstructured":"Varadan AC, Grasis JA (2025) Filamentous bacteriophage M13 induces proinflammatory responses in intestinal epithelial cells. Infect Immun 93(5):e0061824. https:\/\/doi.org\/10.1128\/iai.00618-24","DOI":"10.1128\/iai.00618-24"},{"key":"13695_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.654038","author":"L Walsh","year":"2021","unstructured":"Walsh L, Johnson CN, Hill C, Ross RP (2021) Efficacy of phage- and bacteriocin-based therapies in combatting nosocomial MRSA infections. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.654038","journal-title":"Front Mol Biosci"},{"key":"13695_CR54","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1159\/000486117","volume":"44","author":"S Yin","year":"2017","unstructured":"Yin S, Huang G, Zhang Y, Jiang B, Yang Z, Dong Z, You B, Yuan Z, Hu F, Zhao Y et al (2017) Phage Abp1 rescues human cells and mice from infection by pan-drug resistant Acinetobacter baumannii. Cell Physiol Biochem 44:2337\u20132345. https:\/\/doi.org\/10.1159\/000486117","journal-title":"Cell Physiol Biochem"},{"key":"13695_CR55","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/v14061170","volume":"14","author":"M \u017baczek","year":"2022","unstructured":"\u017baczek M, G\u00f3rski A, Weber-D\u0105browska B, Letkiewicz S, Fortuna W, Rog\u00f3\u017c P, Pasternak E, Mi\u0119dzybrodzki R (2022) A thorough synthesis of phage therapy unit activity in Poland\u2014its history, milestones and international recognition. Viruses 14:1170. https:\/\/doi.org\/10.3390\/v14061170","journal-title":"Viruses"},{"key":"13695_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01614","author":"L Zhang","year":"2018","unstructured":"Zhang L, Hou X, Sun L, He T, Wei R, Pang M, Wang R (2018) Staphylococcus aureus bacteriophage suppresses LPS-induced inflammation in MAC-T bovine mammary epithelial cells. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.01614","journal-title":"Front Microbiol"},{"key":"13695_CR57","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00228-023-03542-z","volume":"79","author":"D Zhang","year":"2023","unstructured":"Zhang D, Xu Y, Wang X, Hou L, Xing M, Xu S, Guo R, Luo Y (2023) Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis. Eur J Clin Pharmacol 79:1303\u20131314. https:\/\/doi.org\/10.1007\/s00228-023-03542-z","journal-title":"Eur J Clin Pharmacol"},{"key":"13695_CR58","unstructured":"Zimecki M, Artym J, Kocieba M, Weber-Dabrowska B, Lusiak-Szelachowska M, G\u00f3rski A (2008) The concerted action of lactoferrin and bacteriophages in the clearance of bacteria in sublethally infected mice. Postepy Hig Med Dosw (Online) 62:42\u201346"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-025-13695-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:32:16Z","timestamp":1768473136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-025-13695-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13695"],"URL":"https:\/\/doi.org\/10.1007\/s00253-025-13695-9","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}